ESMO 2021-highlights in colorectal cancer.

Weiss, L. Memo. 2022;15(2):114-116. doi: 10.1007/s12254-022-00808-7. Epub 2022 Apr 28.

The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.

Moyo, TK; Mendler, JH; Itzykson, R; Kishtagari, A; Solary, E; Seegmiller, AC; Gerds, AT; Ayers, GD; Dezern, AE; Nazha, A; Valent, P; van de Loosdrecht, AA; Onida, F; Pleyer, L; Cirici, BX; Tibes, R; Geissler, K; Komrokji, RS; Zhang, J; Germing, U; Steensma, DP; Wiseman, DH; Pfeilstoecker, M; Elena, C; Cross, NCP; Luebbert, M; Mesa, RA; Sanz, GF; Platzbecker, U; Patnaik, MM; Padron, E; Santini, V; Fenaux, P; Savona, MR; Kiladjian, JJ; Montalban-Bravo, G. BMC Cancer. 2022 Sep 24;22(1):1013. doi: 10.1186/s12885-022-10073-w.

Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update.

Rinnerthaler, G; Singer, C; Petru, E; Egle, D; Petzer, A; Pluschnig, U; Gampenrieder, SP; Pfeiler, G; Gnant, M; Grunberger, B; Krippl, P; Strasser-Weippl, K; Suppan, C; Brunner, C; Pusch, R; Sandholzer, M; Balic, M; Bartsch, R. Wien Klin Wochenschr.2022 Oct;134(19-20):683-692. doi: 10.1007/s00508-022-02082-3. Epub 2022 Sep 23.

Interim analysis (n=150) of the multi-national, prospective, non-interventional ELEANOR study observing real-life extended adjuvant treatment with neratinib in patients with HER2+/ HR+ early breast cancer (eBC).

Harbeck, N; Wrobel, D; Zaiss, M; Guth, D; Distelrath, A; Terhaag, J; Lorenz, A; Bartsch, R; Breitenstein, U; Schwitter, M; Balic, M; Jackisch, C; Muller, V; Rinnerthaler, G; Schmidt, M; Zaman, K; Schinkothe, T; Luftner, D. ANN ONCOL. 2022; 33: S157-S157.

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase 3 iLLUMINATE trial.

Moreno, C; Greil, R; Demirkan, F; Tedeschi, A; Anz, B; Larratt, L; Simkovic, M; Novak, J; Strugov, V; Gill, D; Gribben, JG; Kwei, K; Dai, S; Hsu, E; Dean, JP; Flinn, IW. Haematologica.2022 Sep 1;107(9):2108-2120. doi: 10.3324/haematol.2021.279012.

CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217).

Folprecht, G; Reinacher-Schick, A; Weitz, J; Lugnier, C; Kraeft, AL; Wisser, S; Aust, DE; Weiss, L; von Bubnoff, N; Kramer, M; Thiede, C; Tannapfel, A. Clin Colorectal Cancer. 2022 Jun;21(2):170-174. doi: 10.1016/j.clcc.2021.09.005. Epub 2021 Sep 15.

Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study.

Nowakowski, GS; Yoon, DH; Peters, A; Mondello, P; Joffe, E; Fleury, I; Greil, R; Ku, M; Marks, R; Kim, K; Zinzani, PL; Trotman, J; Huang, D; Waltl, EE; Winderlich, M; Kurukulasuriya, NC; Ambarkhane, S; Hess, G; Salles, G. Clin Cancer Res. 2022 Sep 15;28(18):4003-4017. doi: 10.1158/1078-0432.CCR-21-3648.

Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study.

Diel, IJ; Greil, R; Janssen, J; Kluike, CW; Behera, B; Abbasi, A; Seesaghur, A; Kellner, M; Jaeger, C; Bjorklof, K; Tomova, A; Haslbauer, F. Support Care Cancer. 2022 Nov;30(11):9267-9278. doi: 10.1007/s00520-022-07333-7. Epub 2022 Sep 6.

Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer.

Singer, CF; Holst, F; Steurer, S; Burandt, EC; Lax, SF; Jakesz, R; Rudas, M; Stoger, H; Greil, R; Sauter, G; Filipits, M; Simon, R; Gnant, M; Abcsg, ABCSG. Clin Cancer Res. 2022 Sep 15;28(18):4112-4120. doi: 10.1158/1078-0432.CCR-21-4328.

Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.

Razis, E; Escudero, MJ; Palmieri, C; Mueller, V; Bartsch, R; Rossi, G; Gam-penrieder, SP; Kolberg, HC; Zdenkowski, N; Pavic, M; Connolly, RM; Rosset, L; Arcuri, J; Tesch, H; Vallejos, C; Retamales, J; Musolino, A; Del Mastro, L; Christodoulou, C; Aebi, S; Paluch-Shimon, S; Gupta, S; Ohno, S; Macpher-son, I; Ekholm, M; Zaman, K; Vidal, M; Chakiba, C; Fumagalli, D; Thulin, A; Witzel, I; Kotecki, N; Gil-Gil, M; Linderholm, B. ESMO Open. 2022 Jun;7(3):100483. doi: 10.1016/j.esmoop.2022.100483. Epub 2022 May 13.